Alzheimer's disease & dementia

New molecule reverses Alzheimer's-like memory decline

A drug candidate developed by Salk researchers, and previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse model of inherited Alzheimer's disease. The new research, published online in ...

Diseases, Conditions, Syndromes

Promising path found for COVID-19 therapeutics

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein—providing a promising path for new COVID-19 therapeutics.

Medications

More efficient drug development with the help of computer models

The coronavirus has the world in its grip. Finding a cure has never been more important. Unfortunately, the development of new drugs for treatment of the COVID-19 disease caused by the virus and development of a vaccine are ...

Oncology & Cancer

RNA drugs one step closer to be being used in cancer treatment

In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules ...

Medical research

Schistosomiasis research: New hope for a neglected disease

It's a disease that's hard to pronounce and even harder to eradicate, but schistosomiasis is worth the effort. Caused by parasitic worms carried by freshwater snails, schistosomiasis leads to about 280,000 deaths each year, ...

Medical research

AQAMAN takes aim at rare neurodegenerative diseases

A synthetic small molecule compound called AQAMAN can prevent and even reverse harmful protein build-up in neurons that is associated with several rare neurodegenerative disorders, including polyglutamine (or polyQ) diseases.

page 16 from 28